Loading...

Societal CDMO, Inc.

SCTLNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.10
$0.01(0.92%)

Societal CDMO, Inc. (SCTL) Stock Overview

Explore Societal CDMO, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.2/100

Key Financials

Market Cap116.1M
P/E Ratio-7.89
EPS (TTM)$-0.14
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.29

SCTL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Societal CDMO, Inc. (SCTL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.89 and a market capitalization of 116.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;